The benefits of adoptive NK transfer include the improvement of anti-cancer responses of autologous NK cells through cytokine stimulation, e.g., IL-2, IL-12, IL-15, IL-18 and IFN-γ type I, which enhance the function and proliferation of natural killer cells. The gene discussed is IL2; the disease is cancer.